# FDA Inspection 1062066 - Ahmed Kaldun Nossuli M.D., Principal Investigator - August 14, 2018

Source: https://www.keypedia.com/records/fda_inspections/ahmed-kaldun-nossuli-md-principal-investigator/2529cb2a-c6b2-41a1-a9c9-553786e90a31
Source feed: FDA_Inspections

> FDA Inspection 1062066 for Ahmed Kaldun Nossuli M.D., Principal Investigator on August 14, 2018. Classification: Voluntary Action Indicated (VAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1062066
- Company Name: Ahmed Kaldun Nossuli M.D., Principal Investigator
- Inspection Date: 2018-08-14
- Classification: Voluntary Action Indicated (VAI)
- Project Area: Bioresearch Monitoring
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1129601 - 2020-09-18](https://www.keypedia.com/records/fda_inspections/ahmed-kaldun-nossuli-md-principal-investigator/b2b9f874-8b05-437f-aeed-f345ce116ac9)
- [FDA Inspection 838900 - 2013-06-10](https://www.keypedia.com/records/fda_inspections/ahmed-kaldun-nossuli-md-principal-investigator/1db526c2-e1ef-44fd-9ec9-4a577907d100)

Company: https://www.keypedia.com/companies/ahmed-kaldun-nossuli-md-principal-investigator/abed3af2-8f50-4693-99cf-ca14db6168d8

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c